Patents by Inventor Shahrokh Shabahang

Shahrokh Shabahang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240016905
    Abstract: Methods of reversing hyperglycemia and suppressing diabetes onset in a patient at risk of developing type 1 diabetes are provided. In particular, a vector system comprising a first expression cassette encoding BCL2 associated X apoptosis regulator (BAX) and a hypermethylated second expression cassette encoding a secreted glutamic acid decarboxylase 65 (sGAD55) are administered to the patient to induce a tolerogenic response.
    Type: Application
    Filed: March 3, 2021
    Publication date: January 18, 2024
    Inventors: Shahrokh SHABAHANG, David ALLEVA, Avnesh S. THAKOR
  • Publication number: 20210364530
    Abstract: The present disclosure provides methods for assaying antibodies and related compositions, systems, and kits. More specifically, the disclosure relates to double-multiplex assays that detect multiple immunoglobulin isotypes against multiple different antigens simultaneously. The double-multiplex assay may be conducted using a single test sample.
    Type: Application
    Filed: May 18, 2021
    Publication date: November 25, 2021
    Inventors: Ge Chen, Shahrokh Shabahang, Hong Liu
  • Patent number: 8642257
    Abstract: Described are diagnostic and pharmaceutical compositions comprising a microorganism or cell containing a DNA sequence encoding a detectable protein or a protein capable of inducing a detectable signal, e.g. a luminescent or fluorescent protein, and, in a particular embodiment, furthermore (a) DNA sequence(s) encoding (a) protein(s) suitable for tumor therapy and/or elimination of metastatic tumors, e.g. a cytotoxic or cytostatic protein.
    Type: Grant
    Filed: July 31, 2002
    Date of Patent: February 4, 2014
    Assignee: Genelux Corporation
    Inventors: Aladar A. Szalay, Yong A. Yu, Shahrokh Shabahang, Tatyana Timiryasova
  • Patent number: 8586022
    Abstract: Provided are diagnostic and pharmaceutical compositions containing a microorganism or a cell containing a DNA molecule encoding a detectable protein or a protein that a detectable signal, such as a luminescent or fluorescent protein. Methods of tumor targeting and tumor imaging using the microorganisms and cells are provided. Also provided are therapeutic methods in which the microorganisms and cells, which can encoded a therapeutic protein, such as a cytotoxic or cytostatic protein, are administered.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: November 19, 2013
    Assignee: Genelux Corporation
    Inventors: Aladar A. Szalay, Yong A. Yu, Tatyana Timiryasova, Shahrokh Shabahang
  • Patent number: 8568707
    Abstract: Provided are diagnostic and pharmaceutical compositions containing a microorganism or a cell containing a DNA molecule encoding a detectable protein or a protein that a detectable signal, such as a luminescent or fluorescent protein. Methods of tumor targeting and tumor imaging using the microorganisms and cells are provided. Also provided are therapeutic methods in which the microorganisms and cells, which can encoded a therapeutic protein, such as a cytotoxic or cytostatic protein, are administered.
    Type: Grant
    Filed: June 10, 2004
    Date of Patent: October 29, 2013
    Assignee: Genelux Corporation
    Inventors: Aladar A. Szalay, Yong A. Yu, Tatyana Timiryasova, Shahrokh Shabahang
  • Patent number: 8137904
    Abstract: Described is the use of a microorganism or cell containing a DNA sequence encoding a detectable protein or a protein capable of inducing a detectable signal, e.g., a luminescent or fluorescent protein for the preparation of a diagnostic composition for diagnosis and/or visualization of wounded or inflamed tissue or a disease associated therewith. Moreover, therapeutic uses are described, wherein the microorganism or cell additionally contain an expressible DNA sequence encoding a protein suitable for therapy, e.g. an enzyme causing cell death or digestion of debris.
    Type: Grant
    Filed: June 5, 2003
    Date of Patent: March 20, 2012
    Assignee: Genelux Corporation
    Inventors: Aladar A. Szalay, Shahrokh Shabahang, Yong A. Yu
  • Publication number: 20090123382
    Abstract: Provided are diagnostic and pharmaceutical compositions containing a microorganism or a cell containing a DNA molecule encoding a detectable protein or a protein that a detectable signal, such as a luminescent or fluorescent protein. Methods of tumor targeting and tumor imaging using the microorganisms and cells are provided. Also provided are therapeutic methods in which the microorganisms and cells, which can encoded a therapeutic protein, such as a cytotoxic or cytostatic protein, are administered.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 14, 2009
    Inventors: Aladar A. Szalay, Yong A. Yu., Tatyana Timiryasova, Shahrokh Shabahang
  • Publication number: 20090117049
    Abstract: Provided are diagnostic and pharmaceutical compositions containing a microorganism or a cell containing a DNA molecule encoding a detectable protein or a protein that a detectable signal, such as a luminescent or fluorescent protein. Methods of tumor targeting and tumor imaging using the microorganisms and cells are provided. Also provided are therapeutic methods in which the microorganisms and cells, which can encoded a therapeutic protein, such as a cytotoxic or cytostatic protein, are administered.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 7, 2009
    Inventors: Aladar A. Szalay, Yong A. Yu, Tatyana Timiryasova, Shahrokh Shabahang
  • Publication number: 20090117047
    Abstract: Provided are diagnostic and pharmaceutical compositions containing a microorganism or a cell containing a DNA molecule encoding a detectable protein or a protein that a detectable signal, such as a luminescent or fluorescent protein. Methods of tumor targeting and tumor imaging using the microorganisms and cells are provided. Also provided are therapeutic methods in which the microorganisms and cells, which can encoded a therapeutic protein, such as a cytotoxic or cytostatic protein, are administered.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 7, 2009
    Inventors: Aladar A. Szalay, Yong A. Yu, Tatyana Timiryasova, Shahrokh Shabahang
  • Publication number: 20090117048
    Abstract: Provided are diagnostic and pharmaceutical compositions containing a microorganism or a cell containing a DNA molecule encoding a detectable protein or a protein that a detectable signal, such as a luminescent or fluorescent protein. Methods of tumor targeting and tumor imaging using the microorganisms and cells are provided. Also provided are therapeutic methods in which the microorganisms and cells, which can encoded a therapeutic protein, such as a cytotoxic or cytostatic protein, are administered.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 7, 2009
    Inventors: Aladar A. Szalay, Yong A. Yu, Tatyana Timiryasova, Shahrokh Shabahang
  • Publication number: 20060057703
    Abstract: A method for the evaluation of a material to determine whether the material is susceptible to bacterial contamination or colonization comprising providing bacteria which are modified to produce a first detectable signal, exposing the material being evaluated to the bacteria and determining whether the first signal is present determining whether the first signal is present on the material or within the material.
    Type: Application
    Filed: November 4, 2005
    Publication date: March 16, 2006
    Inventors: Aladar Szalay, Shahrokh Shabahang, Yong Yu
  • Patent number: 6984374
    Abstract: A method for the evaluation of a material to determine whether the material is susceptible to bacterial contamination or colonization comprising providing bacteria which are modified to produce a first detectable signal, exposing the material being evaluated to the bacteria and determining whether the first signal is present determining whether the first signal is present on the material or within the material.
    Type: Grant
    Filed: January 30, 2003
    Date of Patent: January 10, 2006
    Assignee: Loma Linda University
    Inventors: Aladar A. Szalay, Shahrokh Shabahang, Yong Yu
  • Publication number: 20050249670
    Abstract: Described is the use of a microorganism or cell containing a DNA sequence encoding a detectable protein or a protein capable of inducing a detectable signal, e.g., a luminescent or fluorescent protein for the preparation of a diagnostic composition for diagnosis and/or visualization of wounded or inflamed tissue or a disease associated therewith. Moreover, therapeutic uses are described, wherein said microorganism or cell additionally contain an expressible DNA sequence encoding a protein suitable for therapy, e.g. an enzyme causing cell death or digestion of debris.
    Type: Application
    Filed: June 5, 2003
    Publication date: November 10, 2005
    Inventors: Aladar Szalay, Shahrokh Shabahang, Yong Yu
  • Publication number: 20050069491
    Abstract: Described are diagnostic and pharmaceutical compositions comprising a microorganism or cell containing a DNA sequence encoding a detectable protein or a protein capable of inducing a detectable signal, e.g. a luminescent or fluorescent protein, and, in a particular embodiment, furthermore (a) DNA sequence(s) encoding (a) protein(s) suitable for tumor therapy and/or elimination of metastatic tumors, e.g. a cytotoxic or cytostatic protein.
    Type: Application
    Filed: July 31, 2002
    Publication date: March 31, 2005
    Inventors: Aladar Szalay, Yong Yu, Shahrokh Shabahang, Tatyana Timiryasova
  • Publication number: 20030133949
    Abstract: A method for the evaluation of a material to determine whether the material is susceptible to bacterial contamination or colonization comprising providing bacteria which are modified to produce a first detectable signal, exposing the material being evaluated to the bacteria and determining whether the first signal is present determining whether the first signal is present on the material or within the material.
    Type: Application
    Filed: January 30, 2003
    Publication date: July 17, 2003
    Inventors: Aladar A. Szalay, Shahrokh Shabahang, Yong Yu
  • Publication number: 20010029023
    Abstract: A method for evaluating whether a material will allow bacteria to pass through the material comprising providing bacteria which are modified to produce a first detectable signal, placing the bacteria on a first side of the material being evaluated, and determining whether the first signal is present on a second side of the material. A method for the evaluation of a material to determine whether the material is susceptible to bacterial contamination or colonization comprising providing bacteria which are modified to produce a first detectable signal, exposing the material being evaluated to the bacteria and determining whether the first signal is present on the material.
    Type: Application
    Filed: January 25, 2001
    Publication date: October 11, 2001
    Inventors: Aladar A. Szalay, Shahrokh Shabahang, Yong Yu